HCV prevalence has changed significantly world-wide, showing a decreasing trend in the developed world due to a decrease in infections among injecting drug users, the effect of harm reduction programs, and the reduced risk of transfusion-associated acute HCV.
← all excerpts
Direct medical care costs associated with patients diagnosed with chronic HCV.
1
—
—